Omega Diagnostics Group PLC has successfully launched its Allergodip® India enzyme immunoassay (EIA) at the recent World Allergy Organization International Scientific Conference (WISC 2012), held in Hyderabad, India, from the 6th to the 9th of December.
Allergodip India is an adaptation of Omega Diagnostic’s popular Allergodip assay, and offers customized allergen panels for the Indian marketplace.
This semi-quantitative EIA for the determination of Specific IgE in serum or plasma is designed to screen for the most common triggers of allergic diseases in India, and is currently available as two panels; Inhalation - India, and Food - India.
Allergodip India is an easy-to-use, simple test that generates a clear, visual result by comparison of the assay dipstick with a color chart.
No laboratory equipment is necessary, eliminating capital expenditure and the need for a service contract.
Quality of results is ensured by integrated positive and negative controls, and the assay has a diagnostic specificity of 100 % and a sensitivity of 97.5 %.
Allergodip India is supplied with ready-to-use reagents and requires minimal hands-on time, helping to reduce errors and saving time, freeing up staff for other activities.
Allergodip India was very well received at the Conference, with many delegates expressing an interest in the new product.
The recent opening of its direct subsidiary based in Mumbai in July 2012 will make this new range a key focus for Omega Diagnostics in India going forwards.